Shanghai IVEN Pharmatech Engineering Co. Ltd. has successfully completed a modern intravenous (IV) solution pharmaceutical plant for a US Client in the United States, marking a historic milestone as ...

Monte Rosa’s MRT-8102 Phase 1 shows deep NEK7 degradation and strong hsCRP drops; plus $200M raise extends runway. Learn more ...

Across FY26–28, Jefferies forecasts double-digit revenue growth for the sector, led by Biocon (14%), boosted by upcoming ...

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

Monte Rosa Therapeutics (GLUE) commenced an underwritten public offering of $200M of common stock and pre-funded warrants. All shares and warrants in the offering are being sold by the company.

Trading under DCOY to commence on January 8, 2026Company’s proprietary peptide-conjugate platform leverages AI-enabled computational ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...

Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical ...

LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) , the global leader in digital validation and ...

Image Analysis Group and Ferring validate AI imaging biomarkers with FCI and Dexeus to optimize conception timing and personalize fertility care. Image-centric AI collaboration between Image Analysis ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are ...